SEC Form 4 · accession 0000899243-18-017635
scPharmaceuticals Inc. · SCPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Klaus R Dr Veitinger
Director
Period of report
Jun 19, 2018
Accepted (ET)
Jun 21, 2018 · 6:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604950
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.53 | Jun 19, 2018 | A | 6,124 | A | Jun 19, 2019 | Jun 19, 2028 | Common Stock | 6,124 | 6,124 | D |
Explanation of responses
- F1This stock option vests in full upon the earlier of (i) June 19, 2019, and (ii) the next annual meeting of the Issuer's stockholders.